N@N

Aethlon Medical to Present at the B. Riley 11th Annual Investor Conference

_{//science-technology.news-articles.net/content/2 .. the-b-riley-11th-annual-investor-conference.html}
^{Published in Science and Technology on Tuesday, May 25th 2010 at 6:44 GMT by Market Wire}  

SAN DIEGO--([ BUSINESS WIRE ])--Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced that James A. Joyce, Chairman and Chief Executive Officer of Aethlon Medical, Inc., will present at the B. Riley 11^th Annual Investor Conference on May 26, 2010, at 4:00 p.m. Pacific Time. Investors are urged to listen to the live webcast at:

[ http://www.wsw.com/webcast/brileyco14/aemd.ob/ ].

About Aethlon Medical

Aethlon Medical, Inc. creates diagnostic and therapeutic device solutions for infectious disease and cancer. Our lead product, the Hemopurifier® is the first-in-class medical device to selectively capture circulating viruses and immunosuppressive proteins prior to cell and organ infection. Human studies have documented the ability of our Hemopurifier® to reduce viral load in patients infected with Hepatitis-C virus (HCV) and the Human Immunodeficiency Virus (HIV). Our primary clinical and commercialization focus is to establish the Hemopurifier® as an adjunct therapy to enhance and prolong the benefit of traditional infectious disease drug regimens.

Additional information regarding Aethlon Medical can be accessed online at [ www.aethlonmedical.com ].